Edvard Cock has, as chairman of the Board of Directors of Aqua Bio Technology
ASA, received proxies to vote for 5,735,037 shares at the extraordinary general
meeting on 27 June 2019 (the "EGM") without any voting instructions,
representing approx. 48.77 % of the total shares and votes in the company. The
proxies received are only valid for the EGM and will lapse automatically
thereafter.

Further, Blixen Invest AS, a company wholly-owned by Edvard Cock, holds 500,000
shares in Aqua Bio Technology, and together with the received proxies, Edvard
Cock may therefore vote for 6,235,037 shares, representing approx. 53.02 % of
the votes in the company.

This information is subject to disclosure pursuant to section 4-3 of the
Norwegian Securities Trading Act.